npj Parkinson s Disease · 2022 · 107 citations · 60 references
Life SciencesMicrobiologyPathobiologyMedical MicrobiologyMicrobial EcologyMicrobiome ResearchGut MicrobiomeGut MicrobiotaMicrobiome CompositionMicrobiome DysbiosisParkinson DiseaseParkinsonian DisordersDisease Progression PredictionGut Microbiome AlterationsGut Microbiome DysbiosisGut Microbiota CompositionGut Microbiota DysbiosisMicrobial Ecology Of The GutMovement Disorder BiomarkersShort-chain Fatty Acid Production
To elucidate the relevance of gut dysbiosis in Parkinson's disease (PD) in disease progression, we made random forest models to predict the progression of PD in two years by gut microbiota in 165 PD patients. The area under the receiver operating characteristic curves (AUROCs) of gut microbiota-based models for Hoehn & Yahr (HY) stages 1 and 2 were 0.799 and 0.705, respectively. Similarly, gut microbiota predicted the progression of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) III scores in an early stage of PD with AUROC = 0.728. Decreases of short-chain fatty acid-producing genera, Fusicatenibacter, Faecalibacterium, and Blautia, as well as an increase of mucin-degrading genus Akkermansia, predicted accelerated disease progression. The four genera remained unchanged in two years in PD, indicating that the taxonomic changes were not the consequences of disease progression. PD patients with marked gut dysbiosis may thus be destined to progress faster than those without gut dysbiosis.
60
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.8K citations
Medicine, Neurology, Neuroscience +13
Overdependence on degraded gist memory in Alzheimer's disease.
Neuropsychology · 2006 · 4.7K citations